Currently, less than one-third of individuals
with type 1 diabetes are considered to be in good glycemic control with an A1C
<7%, increasing the risk of short- and long-term complications.
Considering the annual cost of type 1 diabetes
care to the individual, estimated to be
$6,288 per year in a 2010 paper and the increasing price of insulin,
effective and realistic low/no cost strategies to improve glycemic control are
needed not only to reduce the expense to the individual with type 1 diabetes.
But also to prevent the short and long term
complications of poor glycemic control and minimize the negative consequences
of high insulin dosages, such as possible weight gain.
No comments:
Post a Comment